A novel glucagon receptor antagonist inhibits glucagon-mediated biological effects.
Qureshi SA, Rios Candelore M, Xie D, Yang X, Tota LM, Ding VD, Li Z, Bansal A, Miller C, Cohen SM, Jiang G, Brady E, Saperstein R, Duffy JL, Tata JR, Chapman KT, Moller DE, Zhang BB.
Qureshi SA, et al. Among authors: moller de.
Diabetes. 2004 Dec;53(12):3267-73. doi: 10.2337/diabetes.53.12.3267.
Diabetes. 2004.
PMID: 15561959